Safe driving after propofol sedation - Summerlin-Grady L, Austin PN, Gabaldon DA.

PURPOSE: Propofol is a short-acting medication with fast cognitive and psychomotor recovery. However, patients are usually instructed not to drive a motor vehicle for 24  hours after receiving propofol. The purpose of this article was to review the evidenc...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Related Links:

Publication date: Available online 1 April 2020Source: The Journal of Chemical ThermodynamicsAuthor(s): Shihua Dong, Weizhen Sun, Yueyang Jiang, Bing Jia
Source: The Journal of Chemical Thermodynamics - Category: Chemistry Source Type: research
INTRODUCTION: The subjective effects of alcohol, i.e., alcohol expectancies (AE), are important predictors of alcohol use. This three-year longitudinal study examined: 1) the development of enhancement, social, coping, and conformity AE from age 10-16; 2) ...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Conditions:   Fetal Alcohol Spectrum Disorders;   Fetal Alcohol Syndrome;   Fetal Alcohol Effect Interventions:   Other: General information;   Behavioral: Baseline brief intervention;   Behavioral: Remote online booster sessions;   Behavioral: SMS Sponsors:   Wayne State University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   Yale University;   Henry Ford Health System Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Conditions:   Alcohol Use, Unspecified;   Substance Use;   Sex Behavior Interventions:   Drug: PrEP acronym (pre-exposure prophylaxis);   Behavioral: Initial Web Survey;   Behavioral: Interactive Voice Response (IVR) monitoring;   Behavioral: Educational material on alcohol and sexual health behavior;   Behavioral: Interactive Voice Response (IVR) assessment with personal ized information;   Behavioral: Personalized information based on web-based survey responses&standardized information Sponsors:   University ...
Source: - Category: Research Source Type: clinical trials
Condition:   Potential Treatment for Alcohol Dependence-Alcohol Interaction Interventions:   Drug: PT150;   Other: Beverage Sponsors:   Pop Test Oncology LLC;   Pharmacotherapies for Alcohol and Substance Abuse Consortium;   Congressionally Directed Medical Research Programs;   Michael Debakey Veterans Affairs Medical Center;   Baylor College of Medicine Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Ex-government adviser says substances such as psilocybin could have medical valueRestrictions on the use of psychedelic drugs in research should be relaxed to help find new treatments for conditions including mental health disorders, the former government adviser ProfDavid Nutt has said. Nutt was sacked aschair of the advisory committee on the misuse of drugs in October 2009 over his views that ecstasy and LSD are less dangerous than alcohol.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Drugs policy Science policy David Nutt Mental health Society Politics UK news Source Type: news
NIAAA Director Report presentation, Council concept clearance, NIAAA Council Member discussion.Air date: 5/12/2020 1:00:00 PM
Source: Videocast - All Events - Category: General Medicine Tags: Upcoming Events Source Type: video
Industrial&Engineering Chemistry ResearchDOI: 10.1021/acs.iecr.0c00074
Source: Industrial and Engineering Chemical Research - Category: Chemistry Authors: Source Type: research
(Cell Press) Before they were banned about a half century ago, psychedelic drugs like LSD and psilocybin showed promise for treating conditions including alcoholism and some psychiatric disorders. In a commentary publishing April 2 in the journal Cell, researchers say it's time for regulators, scientists, and the public to 'revisit drugs that were once used but fell out of use because of political machinations, especially the war on drugs.'
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news
Publication date: July 2020Source: Biomedicine &Pharmacotherapy, Volume 127Author(s): Jianyi Zhuo, Baoyi Chen, Chaoyue Sun, Tao Jiang, Zhiwei Chen, Yanlu Liu, Juan Nie, Hongmei Yang, Jingna Zheng, Xiaoping Lai, Ziren Su, Chuwen Li, Yucui Li
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research
More News: Alcoholism | Diprivan | Propofol